Psychosis Research Today is a free monthly online journal that collates and summarizes the latest research about Psychosis, including details on clinical depression, schizophrenia, bipolar disorder.

Volume 3 (2007), Issue 7 (July)

1. Identification of functional polymorphisms in the promoter region of the human PICK1 gene and their association with methamphetamine psychosis.
   Am J Psychiatry, 164(7): 1105-14. [Abstract] [Full-text]
2. Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.
   Am J Psychiatry, 164(7): 1061-71. [Abstract] [Full-text]
3. Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison.
   Am J Psychiatry, 164(7): 1050-60. [Abstract] [Full-text]
4. Early use of clozapine for poorly responding first-episode psychosis.
   J Clin Psychopharmacol, 27(4): 369-73. [Abstract] [Full-text]
5. Scurvy: a presenting sign of psychosis.
   J Am Acad Dermatol, 57(2): S8-10. [Abstract] [Full-text]
6. A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis.
   Mol Pharmacol, 72(2): 477-84. [Abstract] [Full-text]
7. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
   Lancet, 370(9584): 319-28. [Abstract] [Full-text]

© 2005-2008 Psychosis Research Today. All Rights Reserved.